Transdermal fentanyl thwarts cancer pain, revives QOL

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.449, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transdermal fentanyl improves QOL in noncancer pain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Transdermal fentanyl transforms pain in osteoarthritis

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Fentanyl transdermal system vs oxycodone for chronic pain

Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Pharmacokinetic Study of a Novel Fentanyl-Containing Matrix Transdermal Patch System in Japanese Patients with Cancer Pain

By Miyazaki Toyo

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 313-325

Adis International

Access to resources Recommend Favorite

Transdermal Fentanyl: An Updated Review of its Pharmacological Properties and Therapeutic Efficacy in Chronic Cancer Pain Control

By Muijsers R.B.R. Wagstaff A.J.

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2289-2307

Adis International

Access to resources Recommend Favorite